No sell transactions available for this period
Sanofi filed its 13F report for Q1 2026 on May 07, 2026. The portfolio totaled 335.96 M reflecting a +8.23% change from the prior quarter, spanning 9 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 0 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Sanofi submitted their Form 13F-HR for the Q1 2026 period on 05/07/2026. This was the only submission for the quarter.
In the Q1 2026 filing, Sanofi reported a managed portfolio value of 335.96 M, consisting of 9 individual positions.
This page displays the raw filing documents. To see which stocks Sanofi bought or sold during Q1 2026, please visit Sanofi's Portfolio Analysis page.